RPS6K: Potential Drug Target and Biomarker (P24355)

Target Name: Ribosomal Protein S6 Kinase, 90kDa

NCBI ID: P24355

Ribosomal Protein S6 Kinase, 90kDa

Other Name(s): None

RPS6K: Potential Drug Target and Biomarker

Ribosomal Protein S6 Kinase (RPS6K), 90kDa (nonspecific subtype), is a protein that plays a crucial role in various cellular processes, including cell signaling, DNA replication, and protein synthesis. It is a key regulator of the ribosome, the protein machine that synthesizes proteins in the cell. RPS6K is often targeted by drugs because of its involvement in various diseases, including cancer, neurodegenerative diseases, and developmental disorders.

The 90kDa nonspecific subtype of RPS6K is a subunit of the protein that consists of 90 amino acid residues. This subunit is found in the A subunit of the RPS6K protein, which is responsible for activating the protein-protein interaction that leads to protein synthesis. The 90kDa subunit plays a critical role in regulating the activity of RPS6K and has been identified as a potential drug target.

One of the key functions of RPS6K is its role in the regulation of protein synthesis. RPS6K is a key regulator of the initiation of protein synthesis, which is the process by which amino acids are added to a growing chain of protein. When a protein is synthesized, RPS6K is activated and binds to the A subunit of the protein. This interaction between RPS6K and the A subunit allows RPS6K to regulate the rate of protein synthesis and ensure that the cell has enough protein to meet its needs.

Another function of RPS6K is its role in the regulation of DNA replication. RPS6K is involved in the regulation of DNA replication by binding to the Min protein. Min is a protein that plays a critical role in the regulation of DNA replication, and RPS6K binding to Min allows the protein to regulate the activity of Min. This regulation of DNA replication is important for the development and maintenance of the cell lineage.

In addition to its roles in protein synthesis and DNA replication, RPS6K is also involved in the regulation of cell signaling. RPS6K has been shown to play a role in the regulation of cell signaling by binding to various signaling proteins. For example, RPS6K has been shown to bind to the protein p120Gsk, which is a negative regulator of the src tyrosine kinase, a protein that is involved in cell signaling. This binding between RPS6K and p120Gsk allows RPS6K to regulate the activity of p120Gsk and modulate the signaling pathways that are involved in cell proliferation and differentiation.

The 90kDa nonspecific subunit of RPS6K has been identified as a potential drug target due to its involvement in various diseases. One of the main reasons for this is the fact that RPS6K is often overexpressed in various diseases, including cancer, neurodegenerative diseases, and developmental disorders. Overexpression of RPS6K has been shown to lead to the development of various diseases, including cancer, neurodegenerative diseases, and developmental disorders.

In addition to its involvement in disease, the 90kDa nonspecific subunit of RPS6K is also a potential biomarker. The over-expression of RPS6K has been shown to be associated with the development of various diseases, including cancer, neurodegenerative diseases, and developmental disorders. Therefore, measuring the level of RPS6K expression in cells or tissues could be a useful biomarker for the diagnosis and treatment of these diseases.

In conclusion, the 90kDa nonspecific subunit of RPS6K is a critical regulator of various cellular processes, including protein synthesis, DNA replication, and cell signaling. Its involvement in these processes makes it an attractive target for drug development, particularly for the treatment of diseases that are characterized by the over-expression of RPS6K. The identification of the 90kDa nonspecific subunit as a potential biomarker for the diagnosis and treatment of these diseases adds to its potential as a drug target. Further research is needed to fully understand the role of RPS6K and its potential as a drug

Protein Name: Ribosomal Protein S6 Kinase, 90kDa (nonspecified Subtype)

The "Ribosomal Protein S6 Kinase, 90kDa Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Ribosomal Protein S6 Kinase, 90kDa comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets